Is Aethlon Medical Stock a Good Investment?
Aethlon Medical Investment Advice | AEMD |
- Examine Aethlon Medical's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Aethlon Medical's leadership team and their track record. Good management can help Aethlon Medical navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact Aethlon Medical's business and its evolving consumer preferences.
- Compare Aethlon Medical's performance and market position to its competitors. Analyze how Aethlon Medical is positioned in terms of product offerings, innovation, and market share.
- Check if Aethlon Medical pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Aethlon Medical's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Aethlon Medical stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Aethlon Medical is a good investment.
Sell | Buy |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Dangerous | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Hyperactively responds to market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Aethlon Medical Stock
Researching Aethlon Medical's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 21.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.47. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aethlon Medical recorded a loss per share of 8.58. The entity last dividend was issued on the 15th of October 2019. The firm had 1:8 split on the 9th of June 2025.
To determine if Aethlon Medical is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Aethlon Medical's research are outlined below:
| Aethlon Medical generated a negative expected return over the last 90 days | |
| Aethlon Medical has high historical volatility and very poor performance | |
| Aethlon Medical may become a speculative penny stock | |
| Aethlon Medical has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (13.39 M) with profit before overhead, payroll, taxes, and interest of 574.25 K. | |
| Aethlon Medical currently holds about 14.92 M in cash with (7.65 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.65. | |
| Aethlon Medical has a frail financial position based on the latest SEC disclosures |
Aethlon Medical uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Aethlon Medical. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Aethlon Medical's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of February 2024 Upcoming Quarterly Report | View | |
| 26th of June 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 26th of June 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of March 2023 Last Financial Announcement | View |
Aethlon Medical's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.55 M.Basic technical analysis of Aethlon Stock
As of the 19th of July, Aethlon Medical shows the Standard Deviation of 8.24, mean deviation of 5.13, and Risk Adjusted Performance of (0.08). Aethlon Medical technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Aethlon Medical standard deviation, as well as the relationship between the treynor ratio and potential upside to decide if Aethlon Medical is priced correctly, providing market reflects its regular price of 1.29 per share. Given that Aethlon Medical is a hitting penny stock territory we recommend to closely look at its jensen alpha.Aethlon Medical's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Aethlon Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Aethlon Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Aethlon Medical insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Aethlon Medical's Outstanding Corporate Bonds
Aethlon Medical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Aethlon Medical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Aethlon bonds can be classified according to their maturity, which is the date when Aethlon Medical has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Understand Aethlon Medical's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Aethlon Medical's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.50) | |||
| Mean Deviation | 5.13 | |||
| Coefficient Of Variation | (1,049) | |||
| Standard Deviation | 8.24 | |||
| Variance | 67.86 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (1.00) | |||
| Total Risk Alpha | (1.95) | |||
| Treynor Ratio | (0.51) | |||
| Maximum Drawdown | 59.13 | |||
| Value At Risk | (12.88) | |||
| Potential Upside | 11.95 | |||
| Skewness | (0.53) | |||
| Kurtosis | 5.95 |
| Risk Adjusted Performance | (0.08) | |||
| Market Risk Adjusted Performance | (0.50) | |||
| Mean Deviation | 5.13 | |||
| Coefficient Of Variation | (1,049) | |||
| Standard Deviation | 8.24 | |||
| Variance | 67.86 | |||
| Information Ratio | (0.11) | |||
| Jensen Alpha | (1.00) | |||
| Total Risk Alpha | (1.95) | |||
| Treynor Ratio | (0.51) | |||
| Maximum Drawdown | 59.13 | |||
| Value At Risk | (12.88) | |||
| Potential Upside | 11.95 | |||
| Skewness | (0.53) | |||
| Kurtosis | 5.95 |
Consider Aethlon Medical's intraday indicators
Aethlon Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Aethlon Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Aethlon Medical time-series forecasting models is one of many Aethlon Medical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Aethlon Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Aethlon Stock media impact
There is far too much social signal, news, headlines, and media speculation about Aethlon Medical that are available to investors today. This information is accessible both publicly - through Aethlon Medical's media outlets and privately, via word of mouth or internal channels. However, regardless of the source, the sheer volume of Aethlon-related data is difficult to distill into actionable insights, especially for investors who are not well-versed in the rapidly evolving tools and techniques of investment management.
A primary focus of Aethlon Medical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Aethlon Medical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Aethlon Medical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Aethlon Medical alpha.
Aethlon Medical Corporate Management
| Michele Bombardiere | VP Controller | Profile | |
| Richard Tullis | Chief Science Officer and VP | Profile | |
| MBA BS | Chief Officer | Profile | |
| MD Fisher | Director CEO | Profile | |
| Steven MD | Chief Officer | Profile | |
| Lee Arnold | Chief Officer | Profile |
Already Invested in Aethlon Medical?
The danger of trading Aethlon Medical is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Aethlon Medical is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Aethlon Medical. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Aethlon Medical is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Aethlon Medical is a strong investment it is important to analyze Aethlon Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aethlon Medical's future performance. For an informed investment choice regarding Aethlon Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aethlon Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Aethlon Stock refer to our How to Trade Aethlon Stock guide.You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aethlon Medical. If investors know Aethlon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aethlon Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Aethlon Medical is measured differently than its book value, which is the value of Aethlon that is recorded on the company's balance sheet. Investors also form their own opinion of Aethlon Medical's value that differs from its market value or its book value, called intrinsic value, which is Aethlon Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aethlon Medical's market value can be influenced by many factors that don't directly affect Aethlon Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Aethlon Medical's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Aethlon Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aethlon Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.